FDA Inspection 1246371 — James P. Zidar MD
The FDA completed an inspection of James P. Zidar MD on August 7, 2024 in Raleigh, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Raleigh, NC (United States)
Additional Details
Clinical Investigator (CI)